Monoclonal antibodies: What you should know about treatment options amid Omicron

By | January 26th, 2022|Prevention|

Monoclonal antibody treatments have helped thousands of Arizonans avoid severe illness after contracting COVID-19. So it’s natural to wonder what becomes of this option with the Food and Drug Administration (FDA) withdrawing approval for two widely used treatments that aren’t effective against the now-dominant Omicron variant. Even without monoclonal antibody treatments made by Eli Lilly [...]